Dihydrouracil Dehydrogenase (NAD+) [dihydrouracildehydrogenasa (NAD+)]
topical
1
- Terms
-
dihydrouracildehydrogenasa
dihydrouracildehydrogenáza
dihydrouracildehydrogenáza (NAD+)
-
Dihydrothymine Dehydrogenase (NAD)
Dihydrouracil Dehydrogenase
Dihydrouracil Dehydrogenase (NAD)
Persistent link
https://www.medvik.cz/link/D050744
Definition
An enzyme that catalyzes the oxidation of 5,6-dihydrouracil to URACIL using NAD as a cofactor. This enzyme also plays a role in the catabolism of the antimetabolite 5-FLUOROURACIL.
- DUI
- D050744 MeSH Browser
- CUI
- M0073260
- Previous indexing
- Oxidoreductases Acting on CH-CH Group Donors (2004-2005); Oxidoreductases (1983-2003)
- History note
- 2006(1970)
- Public note
- 2006; DIHYDROURACIL DEHYDROGENASE (NAD+) was indexed under OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS 2004-2005, OXIDOREDUCTASES 1983-2003, & URACIL 1970-1982
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AN
- analysis
- AI
- antagonists & inhibitors
- BI
- biosynthesis
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- DF
- deficiency
- DE
- drug effects 1
- EC
- economics
- GE
- genetics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PH
- physiology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D08.811.682.660.275
Dihydrodipicolinate Reductase
D08.811.682.660.300
Dihydroorotate Oxidase
D08.811.682.660.390
Enoyl-(Acyl-Carrier Protein) Reductase (NADPH, B-Specific)
D08.811.682.660.490
15-Oxoprostaglandin 13-Reductase
D08.811.682.660.495
Lamin B Receptor
D08.811.682.660.500
Prephenate Dehydrogenase